ERBB2 and breast cancer: However, for the TNBC and HER2+ breast cancer samples,Xiping et al. revealed a positive correlation between the increased expressionlevel of the MALAT1 transcript and the number of metastatic lymph nodes, aswell as an inverse relationship between its expression level and therelapse-free survival rate of patients with the HER2+ subtype of breast cancer[2].